Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
about
Adenosine kinase: exploitation for therapeutic gain.Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury.Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain.Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memoryBeneficial and detrimental role of adenosine signaling in diseases and therapyNeurochemical measurement of adenosine in discrete brain regions of five strains of inbred miceATP-Mediated Compositional Change in Peripheral Myelin Membranes: A Comparative Raman Spectroscopy and Time-Of-Flight Secondary Ion Mass Spectrometry StudyAdenosine receptors as drug targets--what are the challenges?Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity.Adenosine transiently modulates stimulated dopamine release in the caudate-putamen via A1 receptors.When cytokinin, a plant hormone, meets the adenosine A2A receptor: a novel neuroprotectant and lead for treating neurodegenerative disorders?Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly.The Safety of Ingested Caffeine: A Comprehensive Review.Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illnessPresynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmissionPast, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.ATP as a multi-target danger signal in the brain.Purines and neuronal excitability: links to the ketogenic dietBinding of the Antagonist Caffeine to the Human Adenosine Receptor hA2AR in Nearly Physiological ConditionsGenetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy developmentComorbidities in Neurology: Is adenosine the common link?Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated processMolecular Targets of Cannabidiol in Neurological DisordersBlockade of adenosine A2A receptors prevents interleukin-1β-induced exacerbation of neuronal toxicity through a p38 mitogen-activated protein kinase pathway.Effects of a Proprietary Standardized Orthosiphon stamineus Ethanolic Leaf Extract on Enhancing Memory in Sprague Dawley Rats Possibly via Blockade of Adenosine A 2A Receptors.Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia.Glial adenosine kinase--a neuropathological marker of the epileptic brain.The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.Guanosine and its role in neuropathologies.Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes.Modulation of synaptic transmission by adenosine in layer 2/3 of the rat visual cortex in vitro.Electroacupuncture-induced neuroprotection against focal cerebral ischemia in the rat is mediated by adenosine A1 receptors.The Role of Adenosine Signaling in Headache: A Review.Astrocyte immune responses in epilepsy.Adenosine A1 modulators: a patent update (2008 to present).Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents.
P2860
Q26852056-3F81BCA8-90DE-46F2-BD98-F540176F6A3FQ27311418-18B3ED1B-49BD-47CC-BE77-C2377241A67AQ27314066-8A1683F8-A013-4C60-8D33-6F9B2B6E63B4Q27319930-4F35DDA2-C5CB-4216-AF44-4472DE9E6D7EQ28080872-1DDB1F2F-F1A2-431A-A133-47802F6050F0Q28541087-50DC6027-4828-44DD-AE02-2FCD9F008D37Q28550753-3D65003F-A798-41EC-B08B-7802B840986AQ29346491-8730EE6B-AA51-4D7A-8890-938468DA6A07Q30355611-AF914475-8246-4BA9-BDA8-48FC358986CEQ30361797-7780A71D-98E1-4924-A854-FF684C70A764Q31067963-E5AB6D18-2005-4D8F-8F94-19933E8EF8F8Q33616120-6DFF37C3-3E7E-4569-8C22-7715C781D7D5Q33729422-433D4A3C-15A2-4954-961E-CB3972F2BA18Q34014053-3464D4A5-9F88-4D18-B817-03B890EE5234Q34499277-D9760C7A-B5C7-41E6-98BB-1C1E02D05C01Q34615473-C6A60BBC-E9C4-4D1A-B6E9-3200496BF591Q35039222-FB54ECF8-42AB-4B85-A66E-F0E9F3FFD949Q35489240-0B4752F2-42E5-4B13-8C29-236DB03A77E7Q35545478-D682B801-DC4E-4B19-A8F7-588F8FCFB226Q35624347-AF962059-BF0F-40B8-8F11-5275D9B55012Q35636233-80467924-9D51-42E7-B3FB-3457C367AF7CQ35911926-4DDA2817-8360-4214-A1AB-28AAB58562F4Q35956389-7102003D-1570-4750-9747-F4275B47A113Q35969643-16F9015A-DB06-4EF6-890E-D8B4FF51C21CQ36062897-A11DE029-C59D-48B4-9825-FE061C84ACDFQ36157649-9B8919D7-3A27-40F5-B0CB-147F5362D3DEQ36226674-9204D97F-7F85-4696-AB89-A3117FB41243Q36304557-59617448-C5AC-42B6-89F4-48EB8FC2B318Q36597141-92B56E4D-5DC6-4FAB-B190-52A297C339A1Q36912637-B0341A95-EE14-4473-B4C1-678DA090DC05Q37131954-92374350-D5BB-40A2-8935-E9CFDEFCF464Q37256409-32B09475-EC4A-43DE-9E3E-198698F7F1FBQ37325379-23B71484-8284-44A3-B2B3-5E0F35BDF9E4Q37650607-F9CEA100-868F-4B6D-947D-968E93F52D34Q37715322-BDB39FAD-C258-4412-B779-6A0AEA087BE6Q37721517-1F724CF1-A756-4038-98A3-B7819A1CB1E3Q37983788-EB76457E-EC08-4363-BFCD-5B79E945C81EQ38109907-599F1133-1710-4A64-96ED-B161D2D67705Q38358456-81863217-D1AC-45BD-9495-3C0063F575C0Q38395423-183631FA-50D4-4BC3-8036-03BDE67644ED
P2860
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
@en
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
@nl
type
label
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
@en
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
@nl
prefLabel
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
@en
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
@nl
P50
P1476
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
@en
P304
P356
10.1016/J.BBAMEM.2010.12.001
P407
P577
2010-12-09T00:00:00Z